UNSPSC 51162736: Pseudoephedrine sulfate

This classification denotes an alpha-adrenergic agonist with the molecular formula 2C10H15NO.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y9DL7QPE6B, chemically known as bis((s-(r*,r*))-(beta-hydroxy-alpha-methylphenethyl)methylammonium) sulphate but more generally known as pseudoephedrine sulfate, which bears US NIH Compound Identifier 62945. European Medicines Agency schedules Pseudoephedrine sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15044MIG.

UNSPSC 51162736 Pseudoephedrine sulfate is a Commodity code that nominally designates a specific pharmaceutical ingredient, but recent state and local solicitations tagged with this code show minimal alignment with that narrow scope. The most recent opportunities in the block reflect purchases of naloxone, drug deactivation systems, and broad generic multi-source pharmaceuticals and over-the-counter products — categories that fall well outside pseudoephedrine sulfate's specific identity. State and local health departments, county health systems, and cooperative purchasing alliances are the issuing bodies driving activity, but the work being solicited is pharmaceutical procurement at scale, not pseudoephedrine sulfate supply in particular. When state and local procurement offices tag opportunities with this code, they appear to be using it as a catch-all for pharmaceutical and OTC product procurement rather than narrowly for the ingredient itself.

The geographic footprint spans at least Minnesota, Florida, and Oregon based on the most recent opportunities. The Seminole County, Florida IFB (IFB60459723LAS, due July 26, 2023, later noted in the source as July 26, 2023 with a posting date of June 30, 2026) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building. The Minnesota Department of Administration's Office of State Procurement issued an RFP through the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) for generic multi-source pharmaceuticals and OTC products distributed across state and local government facilities in Minnesota and Oregon, with responses due March 26, 2026. The code's actual procurement activity does not support a focused business development strategy around pseudoephedrine sulfate supply; the mismatch between the code's nominal scope and what is actually being bought suggests either broad tagging error or use of the code as a generic pharmaceutical classification placeholder.